KR20190011539A - maufacturing methods of Mugwort essence, and functional food using by the same - Google Patents
maufacturing methods of Mugwort essence, and functional food using by the same Download PDFInfo
- Publication number
- KR20190011539A KR20190011539A KR1020170094195A KR20170094195A KR20190011539A KR 20190011539 A KR20190011539 A KR 20190011539A KR 1020170094195 A KR1020170094195 A KR 1020170094195A KR 20170094195 A KR20170094195 A KR 20170094195A KR 20190011539 A KR20190011539 A KR 20190011539A
- Authority
- KR
- South Korea
- Prior art keywords
- mugwort
- weight
- wormwood
- present
- fortified
- Prior art date
Links
- 235000003261 Artemisia vulgaris Nutrition 0.000 title claims abstract description 149
- 238000000034 method Methods 0.000 title claims abstract description 26
- 235000013376 functional food Nutrition 0.000 title abstract description 5
- 241000269837 Artemisia dubia Species 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 51
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 31
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 31
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 31
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 31
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 31
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 24
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 22
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 22
- 229940010454 licorice Drugs 0.000 claims abstract description 22
- 238000009835 boiling Methods 0.000 claims abstract description 4
- 240000004670 Glycyrrhiza echinata Species 0.000 claims abstract 3
- 240000006891 Artemisia vulgaris Species 0.000 claims description 154
- 240000007594 Oryza sativa Species 0.000 claims description 18
- 235000007164 Oryza sativa Nutrition 0.000 claims description 18
- 235000009566 rice Nutrition 0.000 claims description 18
- 230000032683 aging Effects 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 14
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 11
- 235000008397 ginger Nutrition 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 8
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 8
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- 235000018865 Angelica gigas Nutrition 0.000 claims description 5
- 240000001810 Angelica gigas Species 0.000 claims description 5
- 241001105098 Angelica keiskei Species 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 claims description 2
- 244000281762 Chenopodium ambrosioides Species 0.000 claims description 2
- 235000003484 annual ragweed Nutrition 0.000 claims description 2
- 235000006263 bur ragweed Nutrition 0.000 claims description 2
- 235000003488 common ragweed Nutrition 0.000 claims description 2
- 230000000968 intestinal effect Effects 0.000 claims description 2
- 235000009736 ragweed Nutrition 0.000 claims description 2
- 238000010792 warming Methods 0.000 claims description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 claims 2
- 244000273928 Zingiber officinale Species 0.000 claims 2
- 244000126002 Ziziphus vulgaris Species 0.000 claims 2
- MTVPOQKYYUETRT-UHFFFAOYSA-N Eupatilin Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 MTVPOQKYYUETRT-UHFFFAOYSA-N 0.000 abstract description 30
- FHHSEFRSDKWJKJ-UHFFFAOYSA-N eupafolin Natural products C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=C(O)C(O)=C1 FHHSEFRSDKWJKJ-UHFFFAOYSA-N 0.000 abstract description 30
- DRRWBCNQOKKKOL-UHFFFAOYSA-N eupatilin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(O)C(OC)=C(O)C=C2O1 DRRWBCNQOKKKOL-UHFFFAOYSA-N 0.000 abstract description 30
- AOAPCDXPLWGVGI-UHFFFAOYSA-N jaceosidin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccc(O)c(C)c3 AOAPCDXPLWGVGI-UHFFFAOYSA-N 0.000 abstract description 29
- YFZSQPRYLBGYKE-UHFFFAOYSA-N Jaceoside Natural products C1=C(O)C(OC)=CC(C=2OC3=CC(OC4C(C(O)C(O)C(CO)O4)O)=C(OC)C(O)=C3C(=O)C=2)=C1 YFZSQPRYLBGYKE-UHFFFAOYSA-N 0.000 abstract description 26
- GLAAQZFBFGEBPS-UHFFFAOYSA-N jaceosidin Chemical compound C1=C(O)C(OC)=CC(C=2OC3=CC(O)=C(OC)C(O)=C3C(=O)C=2)=C1 GLAAQZFBFGEBPS-UHFFFAOYSA-N 0.000 abstract description 26
- XRHHDQSPFPQKMS-UHFFFAOYSA-N sudachitin Natural products C1=C(O)C(OC)=CC(C=2OC3=C(OC)C(O)=C(OC)C(O)=C3C(=O)C=2)=C1 XRHHDQSPFPQKMS-UHFFFAOYSA-N 0.000 abstract description 26
- 238000004519 manufacturing process Methods 0.000 abstract description 19
- 240000001851 Artemisia dracunculus Species 0.000 abstract 3
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 abstract 3
- 229940119569 wormwood extract Drugs 0.000 abstract 3
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 32
- 241000255777 Lepidoptera Species 0.000 description 27
- 244000303040 Glycyrrhiza glabra Species 0.000 description 21
- 241001247821 Ziziphus Species 0.000 description 21
- 238000004128 high performance liquid chromatography Methods 0.000 description 18
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 17
- 239000000243 solution Substances 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 13
- 235000019640 taste Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 235000019658 bitter taste Nutrition 0.000 description 11
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 10
- 241000234314 Zingiber Species 0.000 description 9
- 235000013305 food Nutrition 0.000 description 8
- 235000019439 ethyl acetate Nutrition 0.000 description 7
- 238000004445 quantitative analysis Methods 0.000 description 7
- 240000002791 Brassica napus Species 0.000 description 6
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 6
- 241000207925 Leonurus Species 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 5
- 241000282320 Panthera leo Species 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000002044 hexane fraction Substances 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- IQZZFVDIZRWADY-UHFFFAOYSA-N isocoumarin Chemical compound C1=CC=C2C(=O)OC=CC2=C1 IQZZFVDIZRWADY-UHFFFAOYSA-N 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 3
- 206010024229 Leprosy Diseases 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 235000011941 Tilia x europaea Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229960005233 cineole Drugs 0.000 description 3
- 239000002038 ethyl acetate fraction Substances 0.000 description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 2
- 244000208874 Althaea officinalis Species 0.000 description 2
- 235000006576 Althaea officinalis Nutrition 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241000256113 Culicidae Species 0.000 description 2
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- HEVGGTGPGPKZHF-UHFFFAOYSA-N Epilaurene Natural products CC1C(=C)CCC1(C)C1=CC=C(C)C=C1 HEVGGTGPGPKZHF-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- 235000001715 Lentinula edodes Nutrition 0.000 description 2
- 241000238633 Odonata Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 2
- 229960004191 artemisinin Drugs 0.000 description 2
- 229930101531 artemisinin Natural products 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011449 brick Substances 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 2
- 229960001380 cimetidine Drugs 0.000 description 2
- 229930007050 cineol Natural products 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 201000011066 hemangioma Diseases 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 235000001035 marshmallow Nutrition 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 150000007875 phellandrene derivatives Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- USDOQCCMRDNVAH-UHFFFAOYSA-N sigma-cadinene Natural products C1C=C(C)CC2C(C(C)C)CC=C(C)C21 USDOQCCMRDNVAH-UHFFFAOYSA-N 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000019587 texture Nutrition 0.000 description 2
- USDOQCCMRDNVAH-KKUMJFAQSA-N β-cadinene Chemical compound C1C=C(C)C[C@H]2[C@H](C(C)C)CC=C(C)[C@@H]21 USDOQCCMRDNVAH-KKUMJFAQSA-N 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 244000186140 Asperula odorata Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 101100505672 Podospora anserina grisea gene Proteins 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- -1 couprol Natural products 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940083980 lavender extract Drugs 0.000 description 1
- 235000020723 lavender extract Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000012184 tortilla Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/20—Malt products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Abstract
Description
본 발명은 약쑥을 이용한 진액 제조방법에 관한 것으로, 더욱 구체적으로는 약쑥에 대추, 감초를 첨가하여 물 중탕 가열함으로써, 유파티린(eupatilin), 자세오시딘(jaceosidin) 등의 약쑥의 유용성분을 다량으로 용출할 수 있는 약쑥 진액의 제조방법, 및 이를 이용한 기능성 식품에 관한 것이다.More particularly, the present invention relates to a method for producing a sponge using medicinal wormwood, and more particularly, to a medicinal herb such as eupatilin and jaceosidin by adding jujube, licorice, Which can be eluted in a large amount, and a functional food using the same.
쑥은 천연식물로서 뛰어난 약효 때문에 "의초"로 불리기도 하고, 여러 가지 효소와 핵산을 함유한 풍부한 염록체를 가지고 있으며, 식물성 섬유질과 단백질, 양질의 미네랄과 다양한 비타민을 함유하고 있다. 또한, 강한 알칼리성 식품으로 산성화된 현대인의 체질을 개선하고 피를 맑게 해주며 약제로서 신체의 부조화를 막아 혈액순환과 소화를 돕고, 인체에 해로운 독성물질을 제압, 제거하는데 효과가 있는 것으로 알려져 있다. 또한, 비타민 A와 C를 많이 함유하고 있어 면역력을 높여주고 감기 예방에 도움을 준다. Mugwort is a natural plant, because it has excellent efficacy. It is also called "herb". It has a rich salt containing various enzymes and nucleic acids. It contains vegetable fiber and protein, high quality minerals and various vitamins. In addition, it is known to improve the constitution of modern people who are acidified with strong alkaline foods, to clear blood, to prevent blood circulation and digestion by preventing the incongruity of the body as a medicine, and to suppress and remove toxic substances harmful to human body. In addition, it contains a lot of vitamins A and C to boost immunity and helps prevent colds.
쑥의 유효성분으로는 아이소쿠마린(isocoumarin), 쿠마린(coumarin), 디터펜락톤(diterpenlactone), 플라보노이드(flavonoid), 펠란드렌(phellandrene), 쿠프롤(couprol), 카디넨(cadinene), 시네올(cineol), 아테미시닌(artemisinin), 유파티린(eupatilin), 자세오시딘(jaceosidin) 등이 밝혀져 있다. The active ingredients of mugwort include isocoumarin, coumarin, diterpenlactone, flavonoid, phellandrene, couprol, cadinene, cineole, cineol, artemisinin, eupatilin, and jaceosidin have been identified.
쑥의 약리작용으로는 쑥의 추출물이 혈장응고 억제작용을 나타내고 쑥으로부터 추출한 플라본은 항암효과가 있다고 알려졌다. 또한 항균작용과 항산화작용을 하여 알러지나 염증에 효과가 좋다. The pharmacological action of mugwort showed that the extract of mugwort showed the anticoagulant effect and the flavone extracted from mugwort had the anticancer effect. It also has antimicrobial and antioxidant properties and is effective against allergies and inflammation.
또한, 유파티린(Eupatilin)은 혈당의 상승, 저하 및 약리적 활성에 관여하고, 위 점액분비촉진에 의한 위벽 보호작용이 기존에 쓰이던 시메티딘보다 3.5배 강한 작용을 보인다고 보고되어 있다. In addition, Eupatilin is involved in the increase, decrease and pharmacological activity of blood glucose, and it has been reported that the gastric wall-protecting action by promoting gastric mucus secretion is 3.5 times stronger than the conventional cimetidine.
또한, 자세오시딘(jaceosidin)은 혈관형성과 관련된 질병인 류마티스성 관절염, 만성염증, 당노병성 망막증, 혈관종 등의 질병치료에 효과가 좋은 성분이다. In addition, jaceosidin is an effective ingredient for the treatment of diseases related to angiogenesis such as rheumatoid arthritis, chronic inflammation, diabetic retinopathy, and hemangioma.
종래 약쑥을 이용한 식품들은 단순히 약쑥을 말린 후 분쇄하여 사용하거나, 또는 이의 열수 추출물을 우려내어 사용함으로써 약쑥에 함유되어 있는 유용성분들이 충분히 발휘되지 못하는 문제점이 있다. Conventionally, foods using mugwort have a problem in that they can not sufficiently exhibit the usefulness of ingredients contained in mugwort by simply using mugwort after drying and then pulverizing or using its hot water extract.
또한, 종래의 다양한 약쑥 식품들은 탁도가 좋지 못하고, 찌꺼기가 많으며, 쓴맛이 너무 강하거나 향이 너무 진해서 선호도를 높이지 못하는 문제점도 있다. 특히, 일반적인 약쑥의 경우 항암이나 위궤양 치료에 효과를 우수하게 이끌어내지 못하는 한계가 있다. In addition, various conventional wormwood foods have problems in that their turbidity is poor, they are large in debris, their bitter taste is too strong, and their flavor is too thick. Especially, common mugwort has a limitation that it can not lead to excellent effects in the treatment of cancer and gastric ulcer.
본 발명은 상기한 문제점을 해결하기 위한 것으로, 약쑥의 유용성분인 유파티린(eupatilin) 및 자세오시딘(jaceosidin) 등의 유용성분을 다량으로 추출하는 것이 목적이다. Disclosure of Invention Technical Problem [8] Accordingly, the present invention has been made in view of the above problems, and it is an object of the present invention to extract a large amount of useful components such as eupatilin and jaceosidin.
또한, 본 발명은 유용성분이 다량 포함되어 있어서 생리적 활성 효과가 우수할 뿐만 아니라, 찌꺼기가 많지 않아서 탁도가 좋으며, 쓴맛이 완화되어서 맛과 풍미가 우수한 효과를 가지는 약쑥 진액을 제공하기 위한 것이다. Further, the present invention is to provide a mugwort juice having an excellent effect on physiological activity because it contains a large amount of an oil component, and also has an excellent turbidity and less bitter taste due to less residue, thereby having an excellent taste and flavor.
본 발명의 일 실시형태에 따른 약쑥 진액의 제조방법은, 약쑥을 1년 내지 5년 동안 숙성시키는 단계; 및, 상기 숙성시킨 약쑥에 대추와 감초를 넣고 가열하여 중탕시키는 단계;를 포함한다.According to one embodiment of the present invention, there is provided a method for producing a scalp wax solution comprising aging wormwood for 1 to 5 years; And adding the jujube and licorice to the aged mugwort, heating and warming the mixture.
여기서, 상기 약쑥을 숙성시키는 단계는, 강화사자발약쑥을 수세하고, 상기 수세한 약쑥을 그늘에서 건조하는 단계; 및 상기 건조한 약쑥을 3년 동안 숙성시키는 단계;를 포함하는 것이 바람직하다. The step of aging the mugwort comprises: washing the mugwort mugwort, and drying the water mugwort in the shade; And aging the dried wormwood for 3 years.
그리고, 상기 중탕시키는 것은, 상기 숙성시킨 약쑥 약 15.0 내지 17.0 중량부, 대추 약 0.5 내지 3.0 중량부와 감초 약 0.5 중량부 내지 2.0 중량부를 물 약 50 중량부 70 중량부에 넣고, 약 75 내지 95℃의 온도로 약 30 시간 내지 35 시간 동안 가열하는 것이 바람직하다. The above boiling water is added to about 70 to 95 parts by weight of the aged mugwort, about 15.0 to 17.0 parts by weight of the aged mugwort, about 0.5 to 3.0 parts by weight of the jujube, about 0.5 to 2.0 parts by weight of licorice, Lt; 0 > C for about 30 to 35 hours.
본 발명의 다른 일 실시형태는, 상기한 약쑥 진액의 제조방법에 따라 제조된 진액에 쌀, 엿기름, 익모초, 당귀, 생강을 혼합하되, 상기 약쑥 진액 1 중량부에 대하여 쌀 약 8.3 중량부, 엿기름 약 0.4 중량부, 익모초 약 0.1 중량부, 당귀 약 0.1 중량부, 및 생강 약 0.1 중량부를 포함하여 혼합하여 제조되는 것을 특징으로 하는 약쑥 조청이다. In another embodiment of the present invention, rice, malt, motherwort, Angelica gigas, and ginger are mixed with the shin juice prepared according to the above-mentioned method of making salty shiitake, wherein about 1 part by weight of the salty shiitake is about 8.3 parts by weight of rice, About 0.4 part by weight, about 0.1 part by weight of motherwort, about 0.1 part by weight of Angelica keiskei, and about 0.1 part by weight of ginger.
상기한 본 발명은 약쑥을 수년 동안 숙성시킨 다음 여기에 대추와 감초를 넣고 중탕시킴으로서, 약쑥의 유용성분인 유파티린(eupatilin) 및 자세오시딘(jaceosidin) 등의 유용성분을 다량으로 추출할 수 있는 효과가 있다. In the present invention described above, it is possible to extract a large amount of useful components such as eupatilin and jaceosidin, which are useful ingredients of mugwort, by aging the mugwort mugweed for several years and then adding jujube and licorice thereto to the mugwort There is an effect.
또한, 본 발명에 따른 방법에 의해 제조된 약쑥 진액은 유용성분이 다량 포함되어 있어서 생리적 활성 효과가 우수할 뿐만 아니라, 찌꺼기가 많지 않아서 탁도가 좋으며, 쓴맛이 완화되어서 맛과 풍미가 우수한 효과가 있다. In addition, since the ascorbic acid solution prepared by the method of the present invention contains a large amount of an oil component, it has not only an excellent effect of physiological activity but also a good turbidity due to not much residue, and an excellent bitterness and excellent taste and flavor.
도 1은 본 발명의 일 실시예에 따라 제조된 강화사자발약쑥을 이용하는 강화사자발약쑥 진액의 제조방법을 나타내는 순서도이다.
도 2는 본 발명의 일 제조예에 따른 3 년 숙성과정을 거친 강화사자발약쑥을나타낸 사진이다.
도 3은 본 발명의 일 실시예에 따라 제조된 강화사자발약쑥 진액(실시예 1)(3a), 강화사자발약쑥 조청(실시예 2)(3b), 및 강화사자발약쑥 essential water(비교예 3)(3c)의 분획물 제조 과정을 나타낸 것이다.
도 4는 본 발명의 일 실시예에 따라 제조된 강화사자발약쑥 진액(실시예 1)(4a), 및 강화사자발약쑥 조청(실시예 2)(4b), 및 강화사자발약쑥 essential water(비교예 3)(4c)를 포함하는 강화사자발약쑥 분획물의 얇은층 크로마토그래피(Thin layer chromatograpy) 결과를 나타낸 것이다.
도 5는 본 발명의 일 실시예에 따라 제조된 강화사자발약쑥 진액(5a), 및 강화사자발약쑥 조청(5b), 및 강화사자발약쑥 essential water(비교예3)(5c)를 포함하는 강화사자발약쑥 분획물의 고성능 액체 크로마토그래피(High Performance Liquid Chromatography, HPLC) 결과를 나타낸 것이다.
도 6은 본 발명의 일 실시예에 따라 제조된 강화사자발약쑥 진액, 및 비교예 2의 진액의 성상비교(도 6a,도 6b), 불순물비교(도 6c), 브릭스비교(도 6d, 도 6e)를 나타내는 사진이다.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a flow chart illustrating a method for preparing fortified marshmallow juice using fortified lepidoptera mugwort produced according to an embodiment of the present invention.
FIG. 2 is a photograph showing the rapeseed mugwort which has undergone a three-year aging process according to one embodiment of the present invention.
Figure 3 is a graph showing the results of a comparison between the intensified lavabo mugwort extract (Example 1) (3a), the fortified lambskin mugwort mellifera (Example 2) (3b) (3c). ≪ / RTI >
Figure 4 is a graph showing the results of a comparison between the intensified lavender moxibustion solution (Example 1) (4a), the intensified ladle mugwort mellifera (Example 2) (4b) ) ≪ / RTI > (4c). ≪ Desc / Clms Page number 7 >
Figure 5 shows an example of an enriched lepidoptera including the fortified lepidoptera mugwort extract 5a prepared according to one embodiment of the present invention and the fortified lepidoptera municipal watershed 5b and the fortified lepidoptera essential wort essential water (Comparative Example 3) 5c. High Performance Liquid Chromatography (HPLC) of the fractions.
6 (a), 6 (b), 6 (b), 6 (b), 6 (b) and 6 (b) show the comparison of the properties of the fortified mash mash mash liquid prepared according to the embodiment of the present invention and the mash of Comparative Example 2 ).
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시 예를 가질 수 있는 바, 특정 실시 예들을 도면에 예시하고 상세한 설명에서 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.BRIEF DESCRIPTION OF THE DRAWINGS The present invention is capable of various modifications and various embodiments, and specific embodiments are illustrated in the drawings and will be described in detail in the detailed description. It is to be understood, however, that the invention is not to be limited to the specific embodiments, but includes all modifications, equivalents, and alternatives falling within the spirit and scope of the invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
본 출원에서 사용한 용어는 단지 특정한 실시예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 출원에서, "포함하다" 또는 "가지다" 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다. The terminology used in this application is used only to describe a specific embodiment and is not intended to limit the invention. The singular expressions include plural expressions unless the context clearly dictates otherwise. In the present application, the terms "comprises" or "having" and the like are used to specify that there is a feature, a number, a step, an operation, an element, a component or a combination thereof described in the specification, But do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, or combinations thereof.
제1, 제2 등의 용어는 다양한 구성요소들을 설명하는데 사용될 수 있지만, 상기 구성요소들은 상기 용어들에 의해 한정되어서는 안 된다. 상기 용어들은 하나의 구성요소를 다른 구성요소로부터 구별하는 목적으로만 사용된다.The terms first, second, etc. may be used to describe various components, but the components should not be limited by the terms. The terms are used only for the purpose of distinguishing one component from another.
도 1은 본 발명의 일 실시예에 따라 제조된 약쑥 진액의 제조방법을 나타내는 순서도이다. BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a flow chart showing a method for producing a scalp solution prepared according to an embodiment of the present invention. FIG.
여기에 도시된 바와 같이, 본 발명에 따른 약쑥 진액의 제조방법은 기본적으로 숙성단계(S30)와 중탕 가열 단계(S60)를 포함하여 이루어진다.As shown in the figure, the method for preparing the saline solution according to the present invention basically includes the aging step (S30) and the heating step (S60).
본 발명의 일 구현예는, 상기 숙성단계(S30) 이전에 수세단계(S10)와 건조단계(S20)를 더 포함할 수 있고, 상기 숙성단계(S30) 이후에 절단세척단계(S40)와 혼합 단계(S50)를 더 포함하는 것도 가능하다. One embodiment of the present invention may further include a washing step (S 10) and a drying step (S 20) before the aging step (S 30), and after the aging step (S 30) It is also possible to further include step S50.
즉, 본 발명에 따른 약쑥 진액의 제조방법은 수세단계(S10), 건조단계(S20), 숙성단계(S30), 절단세척단계(S40), 혼합 단계(S50), 및 중탕 가열 단계(S60)를 포함할 수 있다. 좀 더 구체적으로, 본 발명은 약쑥 수세단계(S10), 상기 수세된 약쑥 건조단계(S20), 상기 건조된 약쑥 숙성단계(S30), 상기 숙성된 약쑥 절단세척단계(S40), 상기 절단세척된 약쑥에 대추, 감초, 및 물을 혼합하는 단계(S50), 및 상기 혼합한 혼합물을 가열하여 중탕시키는 중탕 가열 단계(S60)를 포함하는 것이 가능하다. That is, the method for producing the skimmed milk according to the present invention comprises the steps of washing, drying (S20), aging (S30), cutting and washing (S40), mixing (S50) . ≪ / RTI > More particularly, the present invention relates to a process for the production of a medicament which comprises the step of spraying wipes (S10), the step of drying the wrung worms (S20), the step of aging the dried wrights (S30) (S50) of mixing jujube, licorice, and water in mugwort, and heating the mixed mixture to heat the mixture (S60).
아래에서는, 순서대로 본 발명의 방법을 구체적으로 설명한다.Hereinafter, the method of the present invention will be described in detail in order.
먼저, 본 발명은 약쑥을 수세하는 단계(S10)를 포함할 수 있다. 상기 수세단계(S10)는 약쑥을 수세하는 것이다. 수세하는 방법은 특별히 제한되지 않고, 이 기술분야에 알려진 다양한 방법을 포함한다. 예를 들어, 약쑥을 통째로 2~3회 흐르는 물에 세척할 수 있다. 약쑥을 수세하는 것은 약쑥을 숙성시키기 전에 이물질을 걸러냄으로서 숙성 효과를 증가시키기 위한 것이다.First, the present invention may include washing step (S10). The water washing step (S10) is to wash water. The washing method is not particularly limited and includes various methods known in the art. For example, the wormwood can be washed in running water two or three times in total. Washing wormwood is to increase the ripening effect by filtering foreign matter before aging wormwood.
그리고, 본 발명은 약쑥을 이용해서 진액을 제조하는 것에 대한 것으로, 상기 약쑥은 특별히 제한되지 않고, 이 기술분야에 알려진 다양한 것을 포함할 수 있다. 그 중에서도 강화사자발 약쑥을 이용하는 것이 바람직하다. 본 명세서에서 "강화사자발 약쑥"이라 함은 강화도에서 재배된 약쑥을 의미한다. 강화사자발 약쑥은 다른 약쑥에 비교하여 향이 진하고 색깔과 잎의 형태가 우수한 특징을 가진다. 강화사자발 약쑥은 일반쑥에 비하여 강한 박하향을 가지고 있다. 강화사자발 약쑥은 주위가 바다로 둘러싸여 무공해 청정의 강화도 지역에서 염기가 섞인 바람과 바다에서 피어오르는 안개를 머금은 해양성 기후 및 물 빠짐이 좋은 토양에서 자라기 때문에 약성이 우수하여 예로부터 약쑥 중에 으뜸 품종으로 여겨지고 있다. 그 중에서도 단오를 전후로 봄에 채집한 강화사자발 약쑥이 가장 바람직하다. And, the present invention relates to a method for producing a seaweed using wormwood, and the wormwood is not particularly limited and may include various ones known in the art. Among them, it is preferable to use fortified lepidoptera. As used herein, the term " fortified lepidoptera "refers to ragweed grown in Ganghwa Island. Compared to other mugworts, Mugwort mugwort is characterized by its excellent color and leaf shape. Compared with normal mugwort, the strong lepidoptera mugwort has strong myrrh. It is surrounded by the sea and surrounded by the sea. It is considered to be the best cultivar among the wormwood since it has good weatherability due to its marine climate and fountains that grow in the sea, have. Among them, the most preferred is the fortune-telling mugwort collected in the spring before and after the dong.
본 발명의 강화사자발 약쑥은 효과적 측면에서는 각종 질병에 대한 예방과 치료에 효능이 있고, 작용적 측면에서는 억제작용을 통해 진통, 진정, 제지 등 기능 항진을 억제하는 효능을 가지고 있다. 강화사자발 약쑥은 유파티린(eupatilin)과 자세오시딘(jaceosidin) 등의 플라보노이드(flavonoid), 세사민(sesamin)등의 페닐프로파노이드(phenylpropanoid) 등 다양한 생리 활성 성분을 함유하고 있다. 그 중에서도, 유파티린(Eupatilin)은 혈당의 상승, 저하 및 약리적 활성에 관여하고, 위 점액분비촉진에 의한 위벽 보호작용이 기존에 쓰이던 시메티딘보다 3.5배 강한 작용을 보인다고 보고되어 있다. 유파티린(eupatilin)은 서해안에 자생하는 약쑥에만 다량 함유되어 있는 강화약쑥의 지표성분으로 위염 및 위궤양 치료 효과, 항염증 활성, 면역반응 억제, 담즙산으로 유도된 간세포, 위암세포, 혈액암세포의 세포사멸(apoptosis) 등의 활성에 우수한 효능이 있다. 또한, 자세오시딘(jaceosidin)은 혈관형성과 관련된 질병인 류마티스성 관절염, 만성염증, 당노병성 망막증, 혈관종 등의 질병치료에 효과가 좋은 성분이다.The enhanced rapeseed mugwort of the present invention has an efficacy in preventing and treating various diseases, and in an action aspect, it has an effect of suppressing hyperactivity such as analgesia, sedation, papermaking through inhibitory action. Enhanced lysozyme mugwort contains various physiologically active ingredients such as flavonoids such as eupatilin and jaceosidin, and phenylpropanoid such as sesamin. Among them, Eupatilin is involved in the rise, fall and pharmacological activity of blood glucose, and it has been reported that the gastric wall protecting action by promoting gastric mucus secretion is 3.5 times stronger than the conventional cimetidine. Eupatilin is an indicator component of mugwort mugwort, which is contained only in a large amount of mugwort native to the west coast. It is an indicator component of gastritis and gastric ulcer treatment, anti-inflammatory activity, suppression of immune response, hepatocytes induced by bile acid, gastric cancer cells, It has excellent efficacy for activities such as apoptosis. In addition, jaceosidin is an effective ingredient for the treatment of diseases related to angiogenesis such as rheumatoid arthritis, chronic inflammation, diabetic retinopathy, and hemangioma.
다음으로, 본 발명은 상기 수세된 약쑥을 건조하는 단계(S20)를 더 포함하는 것도 가능하다. 즉, 상기 건조단계(S20)는 상기 수세된 약쑥을 건조하는 것이다. 약쑥의 숙성 전에 약쑥을 건조시킴으로서 약쑥의 보존기간을 늘이고, 약쑥의 맛과 풍미를 증가시키기 위한 것이다. 약쑥을 건조하는 방법은 특별히 제한되지 않는다. 예를 들어서, 실내에서 통풍시켜 건조시키거나 열풍 건조기를 이용하여 건조시킬 수 있다. 비닐하우스나 노지에서 적당량의 햇볕을 받고 볕이 들지 않는 창고에서 오래 숙성시킬 수 있으나, 가급적 볕이 들지 않도록 건조시키는 것이 바람직하다. 그 중에서도 수세된 약쑥의 잎과 줄기 안에 포함된 습기를 제거하기 위해 초기 3 일 정도에는 햇빛에 말리고, 이후에는 건조시설에서 그늘에서 건조시키는 것이 바람직하다. 이때, 건조시설에 비가림, 차광, 습기방지, 환풍시설, 건조대 등이 마련되어 있으면 보다 효율적으로 건조시킬 수 있다. 약쑥의 품종, 일조량, 습기상태, 건조기간, 온도, 분쇄의 정도, 가공시 여러 작업 등에 따라 약쑥의 색깔이 달라질 수 있으므로, 약쑥을 잘 건조시키는 것이 중요하다.Next, the present invention may further comprise a step (S20) of drying the washed wormwood. That is, in the drying step (S20), the washed wormwood is dried. It is intended to increase the preservation period of mugwort, and to increase the taste and flavor of mugwort, by drying mugwort prior to ripening of mugwort. There is no particular limitation on the method of drying mugwort. For example, it can be air-dried in the room or dried using a hot-air dryer. It can be aged for a long time in a warehouse that does not get sunshine in an appropriate amount of sunlight in a plastic house or a garbage, but it is preferable to dry it so that it is not exposed to sunlight as much as possible. Among them, it is preferable to dry in the sun for the first 3 days to remove the moisture contained in the leaves and stems of washed wormwood, and then to dry in the shade at the drying facility. At this time, if the drying facility is provided with rain, shading, moisture prevention, ventilation facilities, drying hood, etc., drying can be performed more efficiently. It is important to dry the mugwort well because the colors of mugwort can vary depending on the varieties of mugwort, the amount of sunshine, the moisture condition, the drying period, the temperature, the degree of grinding, and various operations during processing.
그리고, 본 발명은 약쑥을 숙성시키는 단계(S30)를 포함하는 것이 특징이다. 상기 약쑥으로는 수세 및/또는 건조되지 않은 약쑥을 이용할 수도 있지만, 상기와 같이 수세 및 건조된 약쑥을 이용하는 것이 바람직하다. 약쑥을 숙성시키는 방법은 특별히 제한되지 않는다. 예를 들어, 항아리나 용기에 약쑥을 넣고 소정의 시간동안 적절한 온도 및 습도조건에서 저장 및 보관하는 것이 가능하다. 그 중에서도 숙성기간은 약 1년 내지 약 5 년 동안 숙성시키는 것이 바람직하고, 약 3 년 동안 숙성시키는 것이 더욱 바람직하다. The present invention is characterized by including a step (S30) of aging the wormwood. The mugwort may be water washed and / or dried mugwort, but it is preferable to use water mugwort that has been washed and dried as described above. There is no particular limitation on the method of aging the wormwood. For example, it is possible to store the harvested wormwood in a jar or a container and store and store it under appropriate temperature and humidity conditions for a predetermined period of time. Among them, the ripening period is preferably about one year to about five years, and more preferably about three years.
강화사자발 약쑥의 경우 19 ~ 29 개의 정유성분을 포함하고 있는데, 신선한 생쑥 제품에서는 약 19 개의 정유성분이 검출되지만, 2 년 이상 묵은 사자발 약쑥에서는 29 개의 정유성분이 검출되었다. 또한, 약쑥 내의 주성분의 변화에서도 2 년 동안의 보관에 의해 1,8-cineole은 약 13 배 증가하였고, 신선한 사자발 약쑥의 주성분이었던 trans-b-cayophyllene은 검출되지 않는 등의 변화가 있었던 것으로 나타났다. 이에 따라, 약쑥은 약 3 년 동안 숙성시켜서 유용한 유용성분을 최대한 함유할 수 있도록 하는 것이 바람직하다. Fortified lepidoptera includes 19 to 29 essential oils. About 19 essential oils are detected in fresh lepidoptera, while 29 essential oils are found in lepidoptera, which is more than 2 years old. In addition, 1,8-cineole increased about 13-fold by storage for 2 years, and trans-b-cayophyllene, which was the main component of fresh lepidoptera, was not detected. Accordingly, it is preferable that the mugwort is aged for about three years so as to maximally contain useful useful components.
이어서, 본 발명은 상기 숙성된 약쑥을 절단 및 세척하는 단계(S40)를 더 포함할 수 있다. 즉, 상기 절단 및 세척 단계(S40)는 상기 숙성된 약쑥을 절단 및 세척하는 것이다. 약쑥을 숙성시킨 다음에, 가열 중탕하기 전에 절단 및 세척함으로서, 가열 중탕의 효과를 더욱 높일 수 있다. 약쑥의 절단 방법과 크기는 특별히 제한되지 않는다. 예를 들어, 약 1 m 정도 되는 약쑥을 약 1 ~ 10 cm 크기로 자르고, 잎과 줄기도 같이 절단한 후에, 세척을 할 수 있다. 바람직하게는, 숙성된 약쑥을 그대로 가열 중탕하는 것보다 약 2 ~ 5 cm 크기로 절단하여 이용하면, 약쑥 내의 유용성분을 추출하는 데 보다 유리하다. Next, the present invention may further comprise a step (S40) of cutting and washing the aged wormwood. That is, the cutting and washing step (S40) is to cut and clean the aged wormwood. It is possible to further enhance the effect of the heated hot water bath by cutting and washing the warm water bath before the hot water bath is matured. The method and size of the cutting method are not particularly limited. For example, it is possible to wash wormwood, which is about 1 m long, about 1 ~ 10 cm in size, after cutting like leaves and stems. Preferably, the aged mugwort is cut into a size of about 2 to 5 cm as compared with the case where the mugwort is heated and boiled, and then it is more advantageous to extract useful components in mugwort.
또한, 본 발명은 상기 약쑥에 대추와 감초를 혼합하는 단계(S50)를 포함하는 것이 특징이다. 즉, 상기 혼합하는 단계(S50)는 상기 숙성시킨 약쑥이나 또는 상기 절단 및 세척된 약쑥에 대추와 감초 및 물을 혼합하는 것이다. 상기 약쑥에 대추와 감초를 넣음으로써, 약쑥의 쓴맛을 완화시키고, 맛과 풍미를 좋게하며, 식감을 높이기 위한 것이다. In addition, the present invention is characterized by including a step (S50) of mixing jujube with licorice. That is, the mixing step (S50) is to mix jujube, liquorice and water in the aged wormwood or the cut and washed wormwood. By adding jujube and licorice to the wormwood, the bitter taste of the wormwood is alleviated, the taste and flavor are improved, and the texture is improved.
약쑥 진액을 제조함에 있어서는, 약쑥의 쓴맛과 강한 향을 적절히 감소시키면서, 혼합재료의 맛이 융화되고, 당도를 높일 수 있어 쓴맛과 단맛이 잘 조화를 이룰 수 있도록 원료를 배합하는 것이 중요하다. 본 발명에서, 상기 약쑥에 대한 대추, 감초, 물의 적절한 혼합 비율은 상기 숙성시킨 약쑥 약 15.0 내지 약 17.0 중량부, 대추 약 0.5 내지 약 3.0 중량부와 감초 약 0.5 중량부 내지 약 2.0 중량부를 물 약 50 중량부 약 70 중량부를 포함하는 것이 바람직하다. 그 중에서도, 상기 숙성시킨 약쑥 약 16.0 내지 약 17.0 중량부, 대추 약 1.5 내지 약 3.0 중량부와 감초 약 1.0 중량부 내지 2.0 중량부를 물 60 중량부 내지 65 중량부를 포함하는 것이 더욱 바람직하나, 이에 제한되지 않는다. It is important to mix the raw material so that the taste of the mixed material can be improved, the sugar content can be increased, and the bitter and sweet taste can be harmonized while suitably reducing the bitter taste and strong flavor of the wolfberry. In the present invention, the proper mixing ratio of jujube, licorice, and water to the mugwort is about 15.0 to about 17.0 parts by weight of the aged mugwort, about 0.5 to about 3.0 parts by weight of the jujube, about 0.5 to about 2.0 parts by weight of licorice, 50 parts by weight and about 70 parts by weight. Among them, it is more preferable that about 16.0 to about 17.0 parts by weight of aged mugwort, about 1.5 to about 3.0 parts by weight of jujube, about 1.0 to 2.0 parts by weight of licorice and 60 to 65 parts by weight of water are more preferable. It does not.
상기 약쑥의 양이 너무 많이 포함되면, 쑥의 향이 너무 강하고, 맛이 써서 식감이 덜하여 기호도가 떨어지며, 이물질이 많아져서 탁도가 나빠진다. 또한, 약쑥의 양이 너무 적으면, 약쑥의 효능을 기대하기 어렵다. 예를 들면, 상기 약쑥에 상기 숙성시킨 약쑥 약 30.0 중량부 이상에 대추와 감초, 물을 포함하면 쑥의 강한 향과 맛, 탁도로 인해 식감이 떨어지게 된다.If the amount of the mugwort is too much, the smell of the mugwort is too strong, the taste is reduced, the texture is decreased due to the taste, and the foreign matter is increased and the turbidity is deteriorated. Also, if the amount of mugwort is too small, the efficacy of mugwort can not be expected. For example, if the mugwort contains more than about 30.0 parts by weight of the mugwort mugwort, if it contains jujube, licorice, or water, the texture of the mugwort is deteriorated due to its strong flavor, taste, and turbidity.
이와 함께, 본 발명은 상기 혼합한 혼합물을 가열하여 중탕하는 단계(S60)를 포함하는 것이 특징이다. 즉, 상기 중탕 가열 단계(S60)는 상기 대추와 감초를 혼합한 혼합물을 가열하여 중탕하는 것이다. 상기 약쑥에 대추, 감초, 물이 혼합된 혼합물을 중탕 가열함으로써, 약쑥의 유용성분을 최대한으로 용출시키고, 대추와 감초 등을 우려내서 진액으로 제조하기 위한 것이다. In addition, the present invention is characterized by including a step (S60) of heating and mixing the mixture. That is, in the heating step S60, the mixture of the jujube and licorice is heated and boiled. The mixture of the mixture of jujube, licorice and water is heated by hot water to make the most useful components of the mugwort dissolve to the fullest extent and jujube and licorice are considered.
가열하여 중탕하는 방법은 특별히 제한되지 않고, 이 기술분야에 알려진 다양한 방법을 포함할 수 있다. 다만, 본 발명에서 상기 가열시키는 것은 약 75℃ 내지 약 95℃의 온도로 약 30 시간 내지 약 35 시간 동안 중탕 가열하는 것이 바람직하다. 중탕 온도가 75℃ 미만이고 시간이 30시간 미만이면 약쑥의 유용성분이 충분히 용출되지 못하는 단점이 있고, 중탕 온도가 95℃ 초과이고 시간이 35시간 초과하면 약쑥에서 전분이 올라와 성상이 탁해지고 발효가 진행되어서 변질되기 쉬우며, 식감이 떨어지는 문제점이 있다. 그래서, 상기 가열시키는 것은 약 80℃ 내지 약 92℃의 온도로 약 32 시간 동안 중탕 가열하는 것이 바람직한데, 이 경우 약쑥의 유용성분도 용출이 잘 되면서, 쑥의 쓴맛과 강한 향은 적절히 감소하고, 당도는 높일 수 있어 쓴맛과 단맛의 조화가 가장 잘 되는 효과가 있다. The method of heating and boiling is not particularly limited and may include various methods known in the art. However, in the present invention, it is preferable that the heating is carried out at a temperature of about 75 ° C to about 95 ° C for about 30 hours to about 35 hours. When the temperature of the water bath is less than 75 캜 and the time is less than 30 hours, there is a disadvantage in that the soluble component of the mugwort is not eluted sufficiently. If the temperature of the water bath exceeds 95 캜 and the time exceeds 35 hours, the starch rises in the mugwort, And is susceptible to deterioration, resulting in poor texture. Therefore, it is preferable to heat the above-mentioned heating at a temperature of about 80 ° C to about 92 ° C for about 32 hours. In this case, the soluble component of the mugwort is also eluted well, and the bitter taste and strong smell of mugwort are appropriately decreased, Can be increased, so that the harmony of the bitter taste and the sweet taste is most effective.
상기한 본 발명에 의하면 약쑥을 수년 동안 숙성시킨 다음 여기에 대추와 감초를 넣고 중탕시킴으로서, 약쑥의 유용성분인 유파티린(eupatilin) 및 자세오시딘(jaceosidin) 등의 유용성분을 다량으로 추출할 수 있는 효과가 있다. 즉, 본 발명은 강화사자발약쑥의 유용성분을 효과적으로 추출해 낼 수 있는 제조 공정을 통하여, 강화사자발약쑥이 보유하고 있는 아이소쿠마린(isocoumarin), 쿠마린(coumarin), 디터펜락톤(diterpenlactone), 플라보노이드(flavonoid), 펠란드렌(phellandrene), 쿠프롤(couprol), 카디넨(cadinene), 시네올(cineol), 아테미시닌(artemisinin), 유파티린(eupatilin), 자세오시딘(jaceosidin) 등의 유효성분을 다량으로 용출시킬 수 있는 효과가 있다. According to the present invention, the mugwort is aged for several years, and then the jujube and licorice are added to the mugwort so that a large amount of useful components such as eupatilin and jaceosidin, which are useful components of mugwort, are extracted There is an effect that can be. That is, the present invention relates to a process for efficiently extracting beneficial ingredients of fortified lysolecithine, comprising the steps of: extracting isocoumarin, coumarin, diterpenlactone, flavonoid, ), Phellandrene, couprol, cadinene, cineol, artemisinin, eupatilin, jaceosidin and the like. There is an effect that a large amount of the component can be eluted.
또한, 본 발명에 따른 방법에 의해 제조된 약쑥 진액은 유용성분이 다량 포함되어 있어서 생리적 활성 효과가 우수할 뿐만 아니라, 찌꺼기가 많지 않아서 탁도가 좋으며, 쓴맛이 완화되어서 맛과 풍미가 우수한 효과가 있다. In addition, since the ascorbic acid solution prepared by the method of the present invention contains a large amount of an oil component, it has not only an excellent effect of physiological activity but also a good turbidity due to not much residue, and an excellent bitterness and excellent taste and flavor.
본 발명의 다른 관점은 상기한 제조방법에 따라 제조되는 약쑥 진액을 이용한 조청의 제조방법 및 이에 따라 제조된 조청이다. Another aspect of the present invention is a method for manufacturing a crude oil using a mugwort solution prepared according to the above-described manufacturing method, and a method for preparing the same.
즉, 본 발명은 상기한 제조방법에 따라 제조되는 약쑥 진액에 쌀, 엿기름, 익모초, 당귀, 생강을 혼합하되, 상기 약쑥 진액 1 중량부에 대하여 쌀 약 8.0 ~ 약 9.0 중량부, 엿기름 약 0.3 ~ 0.6 중량부, 익모초 약 0.1 ~ 0.2 중량부, 당귀 약 0.1 ~ 0.2 중량부, 및 생강 약 0.1 ~ 0.2 중량부를 포함하여 혼합하여 약쑥 조청을 제조할 수 있다.That is, the present invention relates to a method for preparing a rice wine, which comprises mixing rice, malt, motherwort, Angelica gigas, and ginger into a mugwort solution prepared according to the above-described production method, wherein about 8.0 to about 9.0 parts by weight of rice, About 0.1-0.2 parts by weight of Angelica keiskei, about 0.1-0.2 parts by weight of Angelica keiskei, about 0.1-0.2 parts by weight of ginger, and about 0.1-0.2 parts by weight of ginger.
바람직하게는, 약쑥 진액 1 중량부에 대하여 쌀 약 8.3 중량부, 엿기름 약 0.4 중량부, 익모초 약 0.1 중량부, 당귀 약 0.1 중량부, 및 생강 약 0.1 중량부를 포함하여 혼합하여 제조되는 것을 특징으로 하는 약쑥 조청을 제공할 수 있다.Preferably, about 8.3 parts by weight of rice, about 0.4 part by weight of malt, about 0.1 part by weight of motherwort, about 0.1 part by weight of Angelica keiskei, and about 0.1 part by weight of ginger are mixed with 1 part by weight of dried squid liquid Can be provided.
본 발명에 따른 약쑥 조청은 약쑥의 쓴맛을 없애고, 약쑥의 깊은 맛을 더하면서, 아밀라아제 효소가 풍부해 소화흡수에 도움을 주고 칼로리가 낮아 음식량을 조절하는 데 있어 효과가 있다. 본 발명에 따른 제조방법으로 제조된 약쑥 진액을 조청과 같은 식품에 적용하는 경우, 항암, 위궤양 및 부인과 질환의 치료 또는 개선에 탁월한 효과를 이끌어 낼 수 있다.According to the present invention, it is effective in eliminating the bitter taste of dragonflies, adding the deep taste of dragonflies, amylase enzyme rich in digestion and absorption, and low in calories to control the food quantity. When the mugwort solution prepared by the production method according to the present invention is applied to food such as zucchini, excellent effects can be obtained in the treatment or improvement of anti-cancer, gastric ulcer and gynecological diseases.
나아가, 본 발명은 생 쑥이나 건조된 쑥을 찐 후 특정 크기의 입도로 분쇄한 분쇄물; 건조된 쑥을 열수 추출한 추출물; 및 상기 약쑥 진액(엑기스)를 식품에 적용하여 기능성 식품을 제조할 수 있다.Furthermore, the present invention relates to a pulverized product obtained by pulverizing raw mugwort or dried mugwort to a particle size of a specific size; Extracts of dried mugwort in hot water; And the mugwort juice (extract) can be applied to foods to produce functional foods.
또한, 본 발명에 따른 약쑥 진액은 떡류, 면류, 음료수 등과 같은 다양한 식품 및 사료(또는 사료첨가제)에 기능성을 부여하기 위한 소재로서 유용하게 사용될 수 있어 산업성 활용 가능성을 기대할 수 있다.In addition, the mugwort juice according to the present invention can be used as a material for imparting functionality to various foods and feeds (or feed additives) such as rice cakes, noodles, drinks, and the like, so that industrial applicability is expected.
예를 들어, 상기한 약쑥 진액을 이용하면, 떡종류(송편, 개떡, 가래떡, 쑥단자, 인절미, 쑥경단), 냉면, 조청, 식혜, 만두, 칼국수, 청국장, 된장, 고추장, 캔디, 쑥빵, 쑥과자, 초콜릿 등 다양한 식품에 활용할 수 있다. 또한, 쑥비누, 쑥화장품, 쑥음료, 쑥콩나물, 쑥엿과 같은 기타 생활용품으로도 활용할 수 있다.For example, when the above-mentioned mugwort juice is used, it is possible to use the above-mentioned mugwort juice, such as rice cakes (Songpyeon, rice cakes, rice cakes, mugwort tortillas, inflorescence, mugwort dumplings), cold noodles, It can be used for a variety of foods such as wormwood confectionery and chocolate. It can also be used as other household items such as mugwort soap, mugwort cosmetics, mugwort drinks, mugwort bean sprouts, and wormwood syrup.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범주 및 기술사상 범위 내에서 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the present invention. Such variations and modifications are intended to be within the scope of the appended claims.
<< 실시예Example 1> 1> 강화사자발Fortified ralph lauren 약쑥 진액 제조 Mugwort
강화사자발약쑥을 수세하여 준비하였다. 상기 수세된 강화사자발약쑥을 그늘에서 건조하고, 상기 건조된 강화사자발약쑥을 전통방식으로 저온(15~25℃)에서 3 년 동안 숙성시켰다. 상기 3 년 숙성된 강화사자발약쑥을 절단하여 세척하였다. 상기 절단세척된 강화사자발약쑥에 대추, 감초, 물을 혼합하여 중탕 가열하였다. 이때, 강화사자발약쑥은 약 17%, 대추는 약 3%, 감초는 약 2%가 되도록 물과 함께 혼합하였다. 상기 강화사자발약쑥을 포함하는 혼합 재료를 중탕기에 넣고 중탕시켜 약 80℃ 내지 약 92℃의 온도로 약 32 시간 동안 가열시켰다. Strengthened lepidoptera was prepared by washing with water. The washed water liquor was dried in the shade and the dried water liquor wormwood was aged for three years at a low temperature (15-25 ° C) in a conventional manner. The 3-year aged reinforced lepidoptera was cut and washed. The jujube, liquorice, and water were mixed and heated in a hot water bath. At this time, the mixture was mixed with water to make about 17% of mugwort powder, about 3% of jujube, and about 2% of licorice. The mixed material including the above-mentioned reinforced lepidoptera was heated in a hot water bath at a temperature of about 80 째 C to about 92 째 C for about 32 hours.
<< 실시예Example 2> 2> 강화사자발Fortified ralph lauren 약쑥 조청 제조 Manufacture
상기 실시예 1에 따라 제조된 강화사자발 약쑥 진액에 쌀, 엿기름, 익모초, 당귀, 생강을 혼합하되, 상기 강화사자발약쑥 진액 1 중량부에 대하여 쌀 약 8.3 중량부, 엿기름 약 0.4 중량부, 익모초 약 0.1 중량부, 당귀 약 0.1 중량부, 생강 약 0.1 중량부를 포함하여 혼합하여 약쑥 조청을 제조하였다. Rice, maltose, motherwort, Angelica gigas, and ginger were mixed with the fortified lavish mugwort solution prepared in Example 1, and about 8.3 parts by weight of rice, about 0.4 part by weight of maltose, about 0.4 part by weight of rice, 0.1 part by weight, Angelica grisea about 0.1 part by weight, and ginger about 0.1 part by weight.
즉, 상기 실시예 1에 따라 제조된 강화사자발약쑥 진액, 익모초, 당귀, 생강을 넣고 약수를 내었다. 쌀은 씻어서 충분히 물에 불린 후, 강화사자발약쑥 진액을 넣고 물을 첨가하여 고두밥을 만들었다. 이후, 엿기름에 물을 붓고, 손으로 주물러 준 다음 약 2 ~ 3 시간 정도 불렸다. 상기 불린 엿기름에 약수를 부은 후 약 2 ~ 3 회 반복하여 체에 밭치거나 자루에 넣어 꼭 짜서 찌꺼기는 버리고 엿기름물을 받았다. 상기 만들어 두었던 고두밥이 따뜻할 때 보온솥에 넣고 엿기름물을 부어 잘 섞이도록 저어주었다. 약 60℃ 정도의 온도에서 약 7 ~ 8 시간 정도 발효시킨후, 원액만 분리하였다. 분리한 원액을 약한 불에서 뭉근하게 졸여서 강화사자발약쑥 조청을 만들었다. Namely, the fortified leprosy mosquito larvae, motherwort, Angelica gigas, and ginger prepared according to the above Example 1 were put in a pot. The rice was washed and sufficiently poured into water, and then water was added to make a rice cake. Then, the malt was poured into water and rubbed by hand, and it was called for about 2 ~ 3 hours. After pouring the boiled water into the boiled maltose, it was repeated about 2 to 3 times, and then it was sown in a sieve or sacked, and it was squeezed to remove the residue and received maltose water. When the hot pepper that I made was warm, I put it in a hot pot and poured maltous water and stirred it to stir well. After fermentation at a temperature of about 60 ° C for about 7 to 8 hours, only the undiluted solution was separated. The separated juice was soaked in a weak fire so as to make fortified larder.
<< 비교예Comparative Example 1> 온도ㆍ시간 조건이 상이한 1> When the temperature and time conditions are different 강화사자발약쑥Fortified lepidoptera 진액 제조 Manufacture of essence
비교예 1은 실시예 1과 같이 강화사자발약쑥에 대추, 감초, 물을 동일한 혼합 비율로 제조하고, 상기 혼합 재료를 약 60 ~ 75℃ 온도 조건에서 약 24 시간 동안 가열하여 진액을 제조하였다. Comparative Example 1 was prepared in the same mixing ratio of jujube, licorice, and water as in Example 1, and the mixed material was heated at a temperature of about 60 to 75 ° C for about 24 hours to prepare a seaweed.
<< 비교예Comparative Example 2> 재료 혼합 비율이 상이한 2 > material mixing ratio 강화사자발약쑥Fortified lepidoptera 진액 제조 Manufacture of essence
비교예 2는 실시예 1과 나머지 조건은 동일하나, 상기 재료 혼합 비율이 강화사자발약쑥 약 35%, 대추 약 3%, 감초 약 2%가 되도록 물과 함께 혼합하여, 강화사자발약쑥의 함량이 실시예 보다 많이 포함되도록 제조하였다. Comparative Example 2 is the same as that in Example 1 except that the above ingredients are mixed together with water such that the mixing ratio of the materials is about 35%, about 3% of jujube, about 2% of licorice, More than the sample.
<< 비교예Comparative Example 3> 증류법에 의한 3> by distillation 강화사자발약쑥Fortified lepidoptera 추출 extraction
강화사자발약쑥을 수세하여 준비하였다. 상기 수세된 강화사자발약쑥을 그늘에서 건조하고, 상기 건조된 강화사자발약쑥을 저온(15~25℃)에서 3년 동안 숙성시켰다. 이후 본 발명의 실시예와 같이 중탕 가열하는 것이 아니라, 증류 방식에 의해 유효성분을 추출하여 강화사자발약쑥 essential water를 제조하였다. Strengthened lepidoptera was prepared by washing with water. The washed rugged warp mugwort was dried in the shade and the dried warp knotworm mugwort was aged at low temperature (15-25 ° C) for 3 years. Thereafter, the active ingredient was extracted by a distillation method, instead of heating with hot water as in the examples of the present invention, to produce intensely water-soluble essential waxy essential water.
<< 실험예Experimental Example 1> TLC에 의한 1 > 유파티린Yu Patin (( eupatilineupatilin ), ), 자세오시딘Posture osidine (( jaceosidinjaceocidin ) 정량분석) Quantitative analysis
강화사자발약쑥 내 유파티린(eupatilin)과 자세오시딘(jaceosidin) 함량을 분석하기 위하여 하기와 같이 TLC 및 HPLC를 이용하여 실시하였다. In order to analyze the content of eupatilin and jaceosidin in rapeseed mugwort, TLC and HPLC were used as follows.
강화사자발약쑥 내 유용성분 중 유파티린(eupatilin)과 자세오시딘(jaceosidin) 함량을 분석하기 위하여, 실시예 1(강화사자발약쑥 진액), 실시예 2(강화사자발약쑥 조청), 비교예 3(강화사자발약쑥 essential water)을 이용하였다. 비교예 3(강화사자발약쑥 essential water)은 본 발명에 따른 약쑥의 제조방법에서 수세, 건조하고, 3년 숙성시킨 강화사자발약쑥을 중탕 가열시키는 것이 아니라, 강화사자발약쑥을 증류시켜 얻어진 추출물로서, 본 발명에 따른 제조방법에 의한 실시예 1(강화사자발약쑥진액), 실시예 2(강화사자발약쑥 조청)과 유용성분의 추출량을 비교하였다. In order to analyze the eupatilin and jaceosidin contents in the fortified lepidopterous mugwort, Example 1 (fortified lion mugwort), Example 2 (fortified lion mugwort mugwort), Comparative Example 3 Essential water) was used. Comparative Example 3 (Enhanced Lepidoptera essential water) is an extract obtained by distilling water-soluble lepidopterous mugwort, which is not water-heated, dried and aged for 3 years in the method of manufacturing drag mugwort according to the present invention, Example 1 (fortified lemon mugwort) and Example 2 (fortified lambskin mugwort) were compared with the extraction amounts of the useful components by the manufacturing method according to the invention.
먼저, 강화사자발약쑥진액(실시예1), 강화사자발약쑥 조청(실시예 2), 강화사자발약쑥 essential water(비교예 3)를 약 40℃ 이하에서 감압 농축하였다. 이어서, 에틸아세테이트(EtOAc) 용매와 n-헥산(n-hexane) 용매의 1:1 혼합용액과 물 150 ml씩 3 번 반복하여 분획을 나누었다. 그 중에서, 에틸아세테이트- n-헥산(EtOAc-n-hexane) 층을 감압 농축하여 시료를 준비하였다. 본 발명의 일 실시예에 따른 도 3a 내지 3c는, 강화사자발약쑥 진액(실시예 1), 강화사자발약쑥 조청(실시예 2), 강화사자발 essential water(비교예 3)의 분획물 제조 과정을 나타낸 것이다. First, the concentrated mugwort mugwort extract (Example 1), the pressed mugwort mugwort mugwort (Example 2), and the pressed mugwort mugwort essential water (Comparative Example 3) were concentrated under reduced pressure at about 40 ° C or lower. Then, ethyl acetate (EtOAc) and the solvent n - hexane (n -hexane) 1 of solvent divided the first mixed solution and the fraction repeatedly with water by 150 ml 3 times. Among them, ethyl acetate - Samples were prepared by concentration of the hexane (EtOAc- n -hexane) layer pressure-n. 3A to 3C according to an embodiment of the present invention show a process for producing fractions of fortified green lime mugwort (Example 1), fortified lime green mugwort (Example 2), and fortified lime essential water (Comparative Example 3) .
상기 분획물 제조방법(도 3)에 따라 제조한 결과, 유파티린(eupatilin)과 자세오시딘(jaceosidin)이 있을 것이라 예상되는 EtOAc/n-hexane fr.(분획)을 통해 각각 강화사자발약쑥 진액(실시예 1)에서 41.1 mg, 그리고 강화사자발약쑥 조청(실시예 2)에서 99.3 mg, 강화사자발약쑥 essential water(비교예 3)에서 160 mg 의 분획물을 얻었다. As a result of the fractionation preparation process (FIG. 3), it was found that the enriched lepidopterous mugwort solution (fraction) was obtained through EtOAc / n- hexane fr. (Fraction), which is expected to contain eupatilin and jaceosidin (Example 1), and 99.3 mg of the fortified lycopene (Example 2) and 160 mg of the crude lecithin essential oil (Comparative Example 3) were obtained.
TLC(Thin layer chromatograpy)를 이용한 시료 내 유파티린(eupatilin)과 자세오시딘(jaceosidin)을 확인하기 위하여 다음과 같은 조건에서 실시하였다.In order to identify eupatilin and jaceosidin in the sample using TLC (thin layer chromatograpy), the following conditions were used.
* 사용 TLC : SiO2 TLCUse TLC: SiO 2 TLC
* 전개용매 : EtOAc-n-hexane = 1 : 1Evaporation solvent: EtOAc- n- hexane = 1: 1
도 4는 본 발명의 일 실시예에 따라 제조된 강화사자발약쑥 진액(실시예 1, 도4a), 및 강화사자발약쑥 조청(실시예 2, 도4b), 및 강화사자발약쑥 essential water(비교예 3, 도4c)를 포함하는 강화사자발약쑥 분획물의 얇은 층 크로마토그래피(Thin layer chromatograpy) 결과를 나타낸 것이다. 일 실시예에 따른 도 4에 나타난 바와 같이, TLC를 통해 강화사자발약쑥 진액(도 4a)과 강화사자발약쑥 조청(도 4b)에서는 소량 확인할 수 있었고, 강화사자발약쑥 essential water에서 유파티린(eupatilin)과 자세오시딘(jaceosidin)의 존재를 확인할 수 없었다(도 4c).Figure 4 is a graph showing the results of a comparison between the intensified lepromatosophilus extract prepared according to one embodiment of the present invention (Example 1, Figure 4a), the intensified lepidoptera (Example 2, Figure 4b) , Fig. 4c). The results of Thin layer chromatograpy are shown in Fig. As shown in FIG. 4 according to one embodiment, a small amount was confirmed in TLC, and in a small amount in intensified lycopods mugwort (Fig. 4a) and intensified lepidoptera (Fig. 4b). Eupatilin, And the presence of jaceosidin could not be confirmed (FIG. 4C).
<< 실험예Experimental Example 2> 2> HPLCHPLC 에 의한 On by 유파티린Yu Patin (( eupatilineupatilin ), ), 자세오시딘Posture osidine (( jaceosidinjaceocidin ) 정량분석) Quantitative analysis
강화사자발약쑥 내 유파티린(eupatilin)과 자세오시딘(jaceosidin) 함량을 분석하기 위하여 하기와 같이 HPLC를 이용하여 실시하였다. In order to analyze the content of eupatilin and jaceosidin in rapeseed mugwort, HPLC was carried out as follows.
강화사자발약쑥 내 유용성분 중 유파티린(eupatilin)과 자세오시딘(jaceosidin) 함량을 분석하기 위하여, 실시예 1(강화사자발약쑥진액), 실시예 2(강화사자발약쑥조청), 비교예 3(강화사자발약쑥 essential water)을 이용하여, 상기 TLC 정량분석 실험과 동일하게 분획물을 제조하였다. In order to analyze the eupatilin and jaceosidin contents in the fortified lepidopterous mugwort, Example 1 (fortified lion mugwort), Example 2 (fortified lion mugwort mugwort), Comparative Example 3 The purified fractions were prepared in the same manner as in the above TLC quantitative analysis experiment by using liquefied natural mugwort essential water.
먼저, HPLC 분석 시료를 준비하기 위하여, 상기 제조된 여액을 이용하여 0.45 mm 멤브레인 필터(membrane filter)로 여과하였다. First, in order to prepare a HPLC analysis sample, the filtrate was filtered through a 0.45 mm membrane filter.
정량분석을 위한 HPLC 분석 조건은 하기와 같다.The HPLC analysis conditions for quantitative analysis are as follows.
* 기기명 : Waters 600S* Device name: Waters 600S
* Column : Phenomenex C18 column (5 μm, 250 mm Ⅹ 4.6 mm)* Column: Phenomenex C18 column (5 [mu] m, 250 mm x 4.6 mm)
* 검출기 : UV-detector, 330 nm* Detector: UV-detector, 330 nm
* 용출용매 : A - water / B - methanolSolvent: A - water / B - methanol
* 용출속도 : 0.6 ml/min* Dissolution rate: 0.6 ml / min
* injection volume : 20 ㎕* injection volume: 20 μl
HPLC 정량 분석을 하기 위하여, 먼저 표준 시료(standard)의 회귀곡선을 작성하였다. 유파티린(eupatilin)과 자세오시딘(jaceosidin)을 각각 10, 20, 50, 500 ppm (0.01, 0.02, 0.05, 0.5 mg/ml)의 농도로 제조한 후, 상기와 같은 HPLC 조건과 다음과 같은 용매조건으로 20 ㎕ 을 주입하여 회귀곡선을 작성하였다. To perform HPLC quantitative analysis, a regression curve of a standard sample was first prepared. Eupatilin and jaceosidin were prepared at concentrations of 10, 20, 50 and 500 ppm (0.01, 0.02, 0.05 and 0.5 mg / ml), respectively. Regression curves were prepared by injecting 20 μl under the same solvent conditions.
이어서, 분획물 중 유파티린(eupatilin)과 자세오시딘(jaceosidin) 함량을 분석하였다. 상기 제조한 시료 용액에 대해 상기 HPLC 분석 조건에 다음과 같은 용매조건으로 분석하였다. 각 실험은 3회 반복 실시하였다. Then, the contents of eupatilin and jaceosidin in the fractions were analyzed. The thus prepared sample solution was analyzed under the following solvent conditions under the above HPLC analysis conditions. Each experiment was repeated three times.
그리고나서, 유파티린(eupatilin)의 표준시료를 농도 10, 20, 50, 500 ppm (0.01, 0.02, 0.05, 0.5 mg/ml)까지 HPLC 로 분석하여 작성된 회귀곡선에 따라 이 농도 범위에서 얻어진 값을 사용하여 정량하였다. Then, a standard sample of eupatilin was analyzed by HPLC up to concentrations of 10, 20, 50 and 500 ppm (0.01, 0.02, 0.05, 0.5 mg / ml) .
또한, 자세오시딘(jaceosidin)의 표준시료를 농도 10, 20, 50, 500 ppm (0.01, 0.02, 0.05, 0.5 mg/ml)까지 HPLC 로 분석하여 회귀곡선에 따라 이 농도 범위에서 얻어진 값을 사용하여 정량하였다.In addition, standard samples of jaceosidin were analyzed by HPLC up to concentrations of 10, 20, 50 and 500 ppm (0.01, 0.02, 0.05, 0.5 mg / ml) and the values obtained in this concentration range were used according to regression curves Respectively.
HPLC 정량 분석의 결과는 도 5에 나타나 있다. 구체적으로, 본 발명의 일 실시예에 따른 도 5a는 강화사자발약쑥 진액(실시예 1)의 HPLC chromatogram을 나타낸 것이다. 도 5a에서 나타난 바와 같이, 강화사자발약쑥 진액(실시예 1)의 EtOAc/n-hexane 분획물의 HPLC 분석결과는, 유파티린(eupatilin)은 22.586 분에서, 자세오시딘(jaceosidin) 은 18.879 분에서 관측되었다.The results of the HPLC quantitative analysis are shown in FIG. Specifically, FIG. 5A, according to one embodiment of the present invention, shows an HPLC chromatogram of intensified leprosy mosquito larvae (Example 1). As shown in Fig. 5A, the HPLC analysis of the EtOAc / n- hexane fraction of the fortified lambskin mugwort extract (Example 1) showed that the eupatilin was at 22.586 min and the jaceosidin was 18.879 min Was observed.
또한, 본 발명의 일 실시예에 따른 도 5b는 강화사자발약쑥 조청(실시예 2)의 HPLC chromatogram을 나타낸 것이다. 도 5b에서 나타난 바와 같이, 강화사자발약쑥 조청(실시예 2)의 EtOAc/n-hexane 분획물의 HPLC 분석결과는, 유파티린(eupatilin)은 22.950 분에서, 자세오시딘(jaceosidin)은 18.304 분에서 관측되었다.FIG. 5B shows an HPLC chromatogram of the powdered green alga mugwort (Example 2) according to one embodiment of the present invention. As shown in FIG. 5B, the HPLC analysis of the EtOAc / n- hexane fraction of the fortified lycopershopped mugwort (Example 2) revealed that the eupatilin and jaceosidin were at 22.950 min and 18.304 min, respectively Was observed.
한편, 본 발명의 일 비교예에 따른 도 5c는 강화사자발약쑥 essential water(비교예 3)의 HPLC 크로마토그램(cromatogramm)을 나타낸 것이다. 도 5c에서 나타난 바와 같이, 강화사자발약쑥 Essential water(비교예 3)의 EtOAc/n-hexane 분획물의 HPLC 분석결과는 유파티린(eupatilin) 과 자세오시딘(jaceosidin)이 관측되지 않았다.Meanwhile, FIG. 5C according to a comparative example of the present invention shows HPLC chromatogram of the hardened lepidoptera essential water (Comparative Example 3). As shown in FIG. 5C, the HPLC analysis of the EtOAc / n- hexane fraction of the enriched lysolecine essential water (Comparative Example 3) showed no eupatilin and jaceosidin.
따라서, 상기 HPLC 결과에 따른 정량결과들을 종합하여 각 시료의 유파티린(eupatilin)과 자세오시딘(jaceosidin)의 정량결과는 하기의 표 1과 같다. Therefore, the results of quantitative determination of eupatilin and jaceosidin in each sample are summarized in Table 1 below.
* ; EtOAc-n-hexane 분획물 1g 당 eupatilin, jaceosidin 의 함량(단위: mg)*; Contents of eupatilin and jaceosidin per 1 g of EtOAc-n-hexane fraction (unit: mg)
** : 얻어진 값은 3회 반복 실험 결과의 평균 및 표준편차임**: The obtained value is the mean and standard deviation of the experiment results of 3 times
상기 TLC, HPLC 정량 분석 결과에 따르면, 본 발명의 진액 제조방법에 따른 약쑥진액, 약쑥조청의 경우 생리활성 기능이 높은 유파티린(eupatilin)과 자세오시딘(jaceosidin)의 추출 함량을 높일 수 있는 제조방법임을 확인할 수 있다. According to the above TLC and HPLC quantitative analysis results, it is possible to increase the extractability of eupatilin and jaceosidin, which are highly physiologically active, in the case of mugwort juice, It can be confirmed that it is a manufacturing method.
<< 실험예Experimental Example 3> 성상, 불순물, 3> Properties, impurities, 브릭스Briggs 평가 evaluation
본 발명의 일 실시예에 따라 제조된 실시예 1(강화사자발약쑥 진액), 및 비교예 2의 진액의 성상, 불순물, 브릭스를 비교하였다. The properties, impurities, and brix of Example 1 (fortified lemon mugwort solution) and Comparative Example 2 prepared according to one embodiment of the present invention were compared.
도 6은 본 발명의 일 실시예에 따라 제조된 강화사자발약쑥 진액(실시예 1), 및 비교예 2의 진액의 성상비교(도 6a,도 6b), 불순물비교(도 6c), 브릭스 비교(도 6d, 도 6d)를 나타내는 사진이다. 도 6a 및 도 6b에서 살펴보면, 왼쪽은 실시예 1 (강화사자발약쑥 17%), 오른쪽은 비교예 2(강화사자발약쑥 35%) 진액을 나타낸 것으로 약쑥의 함량이 높은 비교예의 진액이 육안으로 볼 때 색깔이 진하게 제조된 것을 확인할 수 있다. 그러나, 음용하는 음료라는 측면에서 볼 때 너무 진한 것은 거부감이 들 수 있으나, 실시예 1(왼쪽, 17% 함량)의 경우 색깔이 더 밝고 연한 것을 확인할 수 있다. FIG. 6 is a graph comparing the properties of the fortified lavender extract (Example 1) prepared according to one embodiment of the present invention and the essence of Comparative Example 2 (FIGS. 6A and 6B), the impurities (FIG. 6C) 6D and 6D). 6A and 6B, the left side shows the case of Example 1 (17% of fortified leprosy mugwort) and the right side shows the case of Comparative Example 2 (35% of fortified lepidoptera) It can be confirmed that the color is made thicker. However, in the case of the drink to be consumed, it may be objectionable to be too thick, but it can be confirmed that the color of Example 1 (left, 17% content) is brighter and lighter.
또한, 도 6c를 살펴보면, 실시예 1(하부) 보다 비교예 2(상부)가 불순물이 많아 더 탁한 것을 확인할 수 있었다. 비교예 2(상부)의 경우, 강화사자발약쑥의 함량이 너무 많아지면, 전분이 많아져서 탁도가 높아지고, 음용시 목걸림 현상이 많아지며, 칼칼하여 뒷맛이 개운하지 않을 수 있다. 따라서, 비교예 2에 비해 실시예 1과 같이 강화사자발약쑥의 함량을 강화사자발약쑥 진액의 17%로 하는 것이 적절함을 확인할 수 있었다. Further, referring to FIG. 6C, it was confirmed that Comparative Example 2 (upper portion) was more turbid than Example 1 (lower portion) because of a large amount of impurities. In the case of Comparative Example 2 (upper part), if the content of reinforcing lavender mugwort is too much, the turbidity is increased due to the increase of the starch, the neck hanging phenomenon is increased when drinking, and the aftertaste may not be calmer. Therefore, it was confirmed that it was appropriate to make the content of reinforced rhizome mugwort 17% as compared with that of Comparative Example 2 as in Example 1.
또한, 도 6d 및 도 6e를 살펴보면, 도 6d는 강화사자발약쑥 17% 함량을 포함하여 제조한 실시예 1에 따른 강화사자발약쑥 진액의 브릭스 결과를 나타낸 것이고, 도 6e는 강화사자발약쑥 35% 함량을 포함하여 제조한 비교예 2에 따른 진액의 브릭스 결과를 나타낸 것이다. 이에 따르면, 실시예 1은 44 브릭스(%), 비교예 2는 38 브릭스(%) 값을 나타내고 있다. 이의 결과를 볼 때, 실시예 1이 비교예 2 보다 브릭스 값이 높아 당도가 높은 것을 확인할 수 있었다. 이는 비교예 2가 실시예 1 보다 강화사자발약쑥 함량이 높아 쓴맛으로 인해 대추나 감초의 단맛을 덜 느낄 수 있는 것을 나타낸다. 6d and 6e, Fig. 6d shows the Bricks result of the fortified lion's mugwort solution according to Example 1 including 17% of the fortified lepidoptera mugwort, Fig. 6e shows the content of 35% ≪ tb > < tb > < TABLE > According to this, Example 1 shows 44 brix (%) and Comparative Example 2 shows 38 brix (%). As a result, it was confirmed that the brick value of Example 1 was higher than that of Comparative Example 2, and that the sugar content was higher. This indicates that Comparative Example 2 has a higher intestinal marshmallow content than that of Example 1, so that it is possible to feel less sweetness of jujube and licorice due to bitter taste.
<< 실험예Experimental Example 4> 약쑥의 맛과 풍미 평가 4> Evaluation of taste and flavor of mugwort
본 발명에 따른 실시예 1(강화사자발약쑥 17% 함량 포함, 80 ~ 92℃, 32 시간), 비교예 1(강화사자발약쑥 17% 함량 포함, 60 ~ 75℃, 24 시간), 비교예 2(강화사자발약쑥 35% 함량 포함, 80 ~ 92℃, 32 시간)를 이용하여 강화사자발약쑥 진액에 대한 색, 향, 맛, 식감 등에 대한 관능 평가를 실시하였다. Comparative Example 1 (including 17% of fortified lepidoptera, at 60 to 75 ° C for 24 hours), Comparative Example 2 (containing 17% of fortified lepidoptera, 32 hours at 80 to 92 ° C) , Flavor, taste, and texture of fortified lambskin mugwort juice were investigated by using 35% content of mugwort powder, 80 ~ 92 ℃, 32 hours).
강화사자발약쑥 진액 (실시예 1, 비교예 1, 2) 관능 평가 결과는 하기 표 2와 같다. (Example 1, Comparative Examples 1 and 2) The sensory evaluation results are shown in Table 2 below.
상기 표 2에서 확인할 수 있는 것과 같이, 본 발명에 따른 실시예 1 의해 제조된 강화사자발약쑥 진액에 대한 색, 향, 맛, 식감 등을 포함한 전반적인 기호도가 비교예에 비해 높게 나타났다. 즉, 실시예 1(강화사자발약쑥 17% 함량 포함, 80 ~ 92℃, 32 시간)의 경우 가장 높은 기호도를 나타내었다.As can be seen from the above Table 2, the overall acceptability including the color, flavor, taste, texture and the like of the rapeseed mugwort solution prepared according to Example 1 of the present invention was higher than that of Comparative Example. That is, the highest preference was shown in Example 1 (including the content of 17% of rapeseed mugwort, 80 to 92 ° C, 32 hours).
상기에서는 본 발명을 특정의 바람직한 실시예에 관련하여 도시하고 설명하였지만, 이하의 특허청구범위에 의해 마련되는 본 발명의 기술적 특징이나 분야를 이탈하지 않는 한도 내에서 본 발명이 다양하게 개조 및 변화될 수 있다는 것은 당업계에서 통상의 지식을 가진 자에게 명백한 것이다.Although the present invention has been shown and described with respect to certain preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the following claims It will be apparent to those skilled in the art.
Claims (4)
상기 숙성시킨 약쑥에 대추와 감초를 넣고 가열하여 중탕시키는 단계;를 포함하는, 약쑥 진액의 제조방법.
Aging wormwood for 1 to 5 years; And
Adding the jujube and licorice to the aged mugwort, and heating and warming the mixture.
상기 약쑥을 숙성시키는 단계는,
강화사자발약쑥을 수세하고, 상기 수세한 약쑥을 그늘에서 건조하는 단계; 및 상기 건조한 약쑥을 3년 동안 숙성시키는 단계;를 포함하는 것을 특징으로 하는, 약쑥 진액의 제조방법.
The method according to claim 1,
The step of aging the ragweed,
A step of washing the intestinal mascara and drying the wrung worm in the shade; And aging the dried wormwood for 3 years. ≪ Desc / Clms Page number 20 >
상기 중탕시키는 것은, 상기 숙성시킨 약쑥 15.0 내지 17.0 중량부, 대추 0.5 내지 3.0 중량부와 감초 0.5 중량부 내지 2.0 중량부를 물 50 중량부 70 중량부에 넣고, 75 내지 95℃의 온도로 30 시간 내지 35 시간 동안 가열하는 것을 특징으로 하는 약쑥 진액의 제조방법.
3. The method of claim 2,
The above-mentioned boiling is carried out by adding 15.0 to 17.0 parts by weight of the aged mugwort, 0.5 to 3.0 parts by weight of jujube and 0.5 to 2.0 parts by weight of licorice in 70 parts by weight of water, And heating for 35 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170094195A KR20190011539A (en) | 2017-07-25 | 2017-07-25 | maufacturing methods of Mugwort essence, and functional food using by the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170094195A KR20190011539A (en) | 2017-07-25 | 2017-07-25 | maufacturing methods of Mugwort essence, and functional food using by the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190011539A true KR20190011539A (en) | 2019-02-07 |
Family
ID=65367059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170094195A KR20190011539A (en) | 2017-07-25 | 2017-07-25 | maufacturing methods of Mugwort essence, and functional food using by the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190011539A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102105270B1 (en) * | 2019-10-21 | 2020-04-27 | 농업회사법인 강화마니(주) | Manufacturing method of chocolate comprising mugwort and grain syrup |
WO2022189156A1 (en) * | 2021-03-09 | 2022-09-15 | Firmenich Sa | Hydroxy- and methoxy-substituted flavonoids and their use |
KR20230077327A (en) * | 2021-11-25 | 2023-06-01 | 주식회사 젠트리바이오 | Composition and manufacturing method for antioxidant and anti-inflammatory effects, mainly containing complexes of natural substance extracts |
KR102629603B1 (en) * | 2022-10-22 | 2024-01-29 | 주식회사 북설악 | Manufacturing method of sweet wormwood liquid |
-
2017
- 2017-07-25 KR KR1020170094195A patent/KR20190011539A/en not_active Application Discontinuation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102105270B1 (en) * | 2019-10-21 | 2020-04-27 | 농업회사법인 강화마니(주) | Manufacturing method of chocolate comprising mugwort and grain syrup |
WO2022189156A1 (en) * | 2021-03-09 | 2022-09-15 | Firmenich Sa | Hydroxy- and methoxy-substituted flavonoids and their use |
CN115315195A (en) * | 2021-03-09 | 2022-11-08 | 弗门尼舍有限公司 | Hydroxy-and methoxy-substituted flavonoids and their use |
KR20230077327A (en) * | 2021-11-25 | 2023-06-01 | 주식회사 젠트리바이오 | Composition and manufacturing method for antioxidant and anti-inflammatory effects, mainly containing complexes of natural substance extracts |
KR102629603B1 (en) * | 2022-10-22 | 2024-01-29 | 주식회사 북설악 | Manufacturing method of sweet wormwood liquid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20190011539A (en) | maufacturing methods of Mugwort essence, and functional food using by the same | |
CN101288430A (en) | Tartary buckwheat green tea and producing method thereof | |
CN103749872B (en) | Bitter buckwheat product of a kind of high added value and preparation method thereof | |
CN107384734A (en) | The preparation method and liver protection and eyesight health care buckwheat vinegar of a kind of liver protection and eyesight health care buckwheat vinegar | |
KR101610267B1 (en) | Method for Manufacturing Dutch Coffee with Glehnia littoralis | |
CN106889386A (en) | A kind of ginger juice and black tea health-care composite beverage and preparation method thereof | |
KR20200082556A (en) | The manufacturing method of health jujube tea including extracts of pear and ginger | |
CN109430612A (en) | A kind of date-wolfberry fruit juice and its production method | |
CN106616109A (en) | Preparation method for ganoderma lucidum beverage | |
CN1059231C (en) | Health-care beer added with bamboo leaf flavone extract | |
KR100894636B1 (en) | A manufacturing process of the beverage including yam extract | |
CN105901458B (en) | A kind of black rice compound solid beverage and preparation method thereof | |
CN107593981A (en) | A kind of processing method of flowers black tea and flowers black tea | |
CN108410635B (en) | Brewing method of cherry tomato fruit wine | |
KR20150054519A (en) | Preparing method of hot pepper paste having yams and artemisia annua and hot pepper paste using the same | |
CN107541415A (en) | A kind of root of kudzu vine alcoholic beverage and preparation method thereof | |
KR20160021643A (en) | Manufacturing Method of Beverage Using Extract from Aronia | |
CN105176766A (en) | Jasmine oat tea wine and preparation method thereof | |
KR20140089292A (en) | Health food composition comprising balsam pear extract as main ingredients and method thereof | |
CN103445243A (en) | Technology and preparation method of persimmon-leaf composite health-care beverage | |
CN107232469A (en) | It is a kind of to retain natural color, smell and taste and the chrysanthemum solid beverage processing method of nutritive value | |
CN105176765A (en) | Strawberry tea wine capable of nourishing yin and blood and preparation method for strawberry tea wine | |
CN110495542A (en) | A kind of cactus solid beverage and preparation method | |
KR20010060838A (en) | Health beverage made from Acanthopanax koreanum Nakai and method for preparation thereof | |
KR20040000942A (en) | Oriental Medicine way soft drink and manufacturing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |